In contrast, RA-differentiated cells from CD1d-negative patient glioblastoma stem-like cells had slightly higher sensitivity to α-GalCer-dependent iNKT cell-mediated cytotoxicity, though the difference was not statistically significant (Supplementary Fig. 1). The gene discussed is CD1D; the disease is glioblastoma.